简介概要

Development of CaP nanocomposites as photothermal actuators for doxorubicin delivery to enhance breast cancer treatment

来源期刊:JOURNAL OF MATERIALS SCIENCE TECHNOLOG2021年第4期

论文作者:Jie Liu Li Li Run Zhang Zhi Ping Xu

摘    要:Breast cancer is the most common one in women worldwide and doxorubicin(Dox) is one of the most commonly used and effective drugs for breast cancer treatment. Unfortunately, Dox-based chemotherapy faces irreversible cardiotoxicity and unsatisfactory therapy efficiency. It is desirable to devise Dox nanoformulations with less adverse effects and greater therapeutic efficacy for this cancer treatment. In this work, a multifunctional calcium phosphate nanoformulation(ICG-Dox/DNA@CaP) was developed by co-loading Dox/DNA complexes and indocyanine green(ICG) molecules for photothermal therapy(PTT)-enhanced chemotherapy. In this nanocomposite, using DNA as Dox carrier facilitated Dox loading into the CaP matrix, and significantly reduced Dox leakage as well as cytotoxicity in comparison with that of free Dox in physiological medium(pH 7.4). In specific, ICG-Dox/DNA@CaP only released Dox in a weakly acidic nuclease-containing environment, such as tumor microenvironment and endosome/lysosome. Moreover,Dox/DNA complexes exhibited synergistic interactions with ICG-based photothermal effect on tumor cell apoptosis in this ICG-Dox/DNA@CaP nanocomposite. This work has demonstrated a new strategy to combine FDA-approved therapeutics(Dox and ICG) in CaP-based nanomaterials for reduced cytotoxicity and enhanced therapeutic effect, and provided a new way to engineer CaP carriers as multifunctional delivery systems for clinical anti-cancer therapy.

详情信息展示

Development of CaP nanocomposites as photothermal actuators for doxorubicin delivery to enhance breast cancer treatment

Jie Liu,Li Li,Run Zhang,Zhi Ping Xu

Australian Institute for Bioengineering and Nanotechnology, The University of Queensland

摘 要:Breast cancer is the most common one in women worldwide and doxorubicin(Dox) is one of the most commonly used and effective drugs for breast cancer treatment. Unfortunately, Dox-based chemotherapy faces irreversible cardiotoxicity and unsatisfactory therapy efficiency. It is desirable to devise Dox nanoformulations with less adverse effects and greater therapeutic efficacy for this cancer treatment. In this work, a multifunctional calcium phosphate nanoformulation(ICG-Dox/DNA@CaP) was developed by co-loading Dox/DNA complexes and indocyanine green(ICG) molecules for photothermal therapy(PTT)-enhanced chemotherapy. In this nanocomposite, using DNA as Dox carrier facilitated Dox loading into the CaP matrix, and significantly reduced Dox leakage as well as cytotoxicity in comparison with that of free Dox in physiological medium(pH 7.4). In specific, ICG-Dox/DNA@CaP only released Dox in a weakly acidic nuclease-containing environment, such as tumor microenvironment and endosome/lysosome. Moreover,Dox/DNA complexes exhibited synergistic interactions with ICG-based photothermal effect on tumor cell apoptosis in this ICG-Dox/DNA@CaP nanocomposite. This work has demonstrated a new strategy to combine FDA-approved therapeutics(Dox and ICG) in CaP-based nanomaterials for reduced cytotoxicity and enhanced therapeutic effect, and provided a new way to engineer CaP carriers as multifunctional delivery systems for clinical anti-cancer therapy.

关键词:

<上一页 1 下一页 >

相关论文

  • 暂无!

相关知识点

  • 暂无!

有色金属在线官网  |   会议  |   在线投稿  |   购买纸书  |   科技图书馆

中南大学出版社 技术支持 版权声明   电话:0731-88830515 88830516   传真:0731-88710482   Email:administrator@cnnmol.com

互联网出版许可证:(署)网出证(京)字第342号   京ICP备17050991号-6      京公网安备11010802042557号